Research Business Alliance Opportunities

To avoid the extraordinary effort and cost of conventional techniques, biologists in the research and clinical communities need low-cost, appliance-like, benchtop molecular interaction systems to rapidly develop free-solution, label-free assays and run routine assays at high sensitivity and low sample volumes.

Molecular Sensing is seeking alliance business partners that are leaders in the bioanalytical tools business who are interested in developing benchtop molecular interaction assay products and are prepared to co-invest in market development, product development, and distribution of BSI systems to customers in academia, government, and industry.

Diagnostic Business Alliance Opportunities

The BSI platform can overcome the current limitations of diagnostic POC and near-patient devices by achieving equivalent performance between these devices and laboratory systems, delivering less than one-minute quantitative assays, generating ELISA or better sensitivity, and having the freedom-to-operate resulting from patents and intellectual property rights.

Molecular Sensing is looking for alliance business partners who are leaders in clinical diagnostics and are developing novel near-patient/POC and/or clinical laboratory instrumentation and are prepared to co-invest in market development, product development, regulatory approval, and distribution of BSI clinical lab and near-patient/POC systems for clinical diagnostic laboratories and physicians.

Contact info@molsense.com to further discuss either of these alliance programs.